EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry

Laura Lupi, Elena Antonioli, Angelica Praderio, Alessandro Villaschi, Elisa Soranzo, Nicola Saccani, Kamil Stankowski, Daniele Cocianni, Beniamino Pagliaro, Valeria Magni, Marco Loffi, Daniela Tomasoni und 6 weitere

European Journal of Heart Failure · 2025

DOI: 10.1002/ejhf.3678 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Laura Lupi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Un…. Hauptthemen laut MEDLINE: Heart Failure, Heart Ventricles, Registries, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To report prevalence and clinical outcomes of different aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation (ASTR/VSTR). Methods and results The Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure (HF) and Valve Clinics (CARE-TR) registry collected data from patients with at least severe tricuspid regurgitation (TR) enrolled at three Italian centres. The present analysis includes 648 patients with secondary TR, 22.1% with ASTR and 77.9% with VSTR. Patients with ASTR were further stratified in those with atrial fibrillation (AF, 25.2%), HF with preserved ejection fraction (HFpEF, 37.8%), and both (37.0%). Patients with VSTR were subdivided into those with severe left-sided valvular heart disease (LS-VHD, 28.5%), HF with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF, 29.1%), HFpEF (35.5%), pre-capillary pulmonary hypertension (PH, 4.0%) and isolated right ventricular dysfunction (RVD, 2.9%). After a median follow-up of 498 days, 118 (18.2%) patients died and 153 (23.6%) were hospitalized for HF. Two-year survival free from the composite outcome of death or HF hospitalization was higher in patients with ASTR compared with those with VSTR (73.5% vs. 54.4%; p < 0.001). After adjustment for variables related with HF severity, VSTR remained independently associated with an increased risk of events (adjusted hazard ratio 2.00; 95% confidence interval 1.33–3.02; p = 0.001). Among ASTR patients, combined AF and HFpEF was associated with a poorer outcome compared with AF or HFpEF alone (60.2% vs. 80.5% vs. 83.6%; p = 0.022). Among patients with VSTR, overall survival free from the composite outcome was 85%, 65%, 54%, 39% and 38% for RVD, HFpEF, HFrEF/HFmrEF, severe LS-VHD, and pre-capillary PH, respectively (p < 0.001).

Conclusions

In a real-world population with at least severe secondary TR, 22% had ASTR and showed better outcomes as compared to VSTR. Among patients with ASTR, combination of AF and HFpEF was common and associated with the worst prognosis. Among patients with VSTR, those with pre-capillary PH had the poorest outcomes, followed by those with LS-VHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHeart VentriclesRegistriesTricuspid Valve InsufficiencyAgedFemaleHumansMaleMiddle AgedAtrial FibrillationEchocardiographyFollow-Up StudiesHeart AtriaItalyPhenotypePrevalencePrognosisSeverity of Illness IndexStroke VolumeSurvival Rate

Stichwörter der Autor:innen

Aetiological phenotypesAtrial secondary tricuspid regurgitationOutcomesPrevalenceVentricular secondary tricuspid regurgitation

Autor:innen und Institutionen

  • Institute of Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Division of Cardiology, ASST del Garda, Presidio Ospedaliero di Manerbio, Manerbio, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
  • Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University Hospital of Trieste, Trieste, Italy.
  • Division of Cardiology, ASST del Garda, Presidio Ospedaliero di Desenzano del Garda, Desenzano del Garda, Italy.
  • Division of Cardiology, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.

Zitieren

APA

Lupi, L., Antonioli, E., Praderio, A., Villaschi, A., Soranzo, E., Saccani, N., Stankowski, K., Cocianni, D., Pagliaro, B., Magni, V., Loffi, M., Tomasoni, D., Pagnesi, M., Mangieri, A., Stolfo, D., Sinagra, G., Adamo, M., & Metra, M. (2025). Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3678

Vancouver

Lupi L, Antonioli E, Praderio A, Villaschi A, Soranzo E, Saccani N, et al. Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3678

BibTeX
@article{Lupi2025,
  author = {Lupi, Laura and Antonioli, Elena and Praderio, Angelica and Villaschi, Alessandro and Soranzo, Elisa and Saccani, Nicola and Stankowski, Kamil and Cocianni, Daniele and Pagliaro, Beniamino and Magni, Valeria and Loffi, Marco and Tomasoni, Daniela and Pagnesi, Matteo and Mangieri, Antonio and Stolfo, Davide and Sinagra, Gianfranco and Adamo, Marianna and Metra, Marco},
  title = {Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry},
  journal = {European Journal of Heart Failure},
  year = {2025},
  doi = {10.1002/ejhf.3678}
}
Kostenlos starten →